Reported symptoms include chest pain, shortness of breath, rapid heart rate, calf pain, and sudden worsening of breathing
Biomarker monitoringincluding fasting glucose, insulin, and lipid panelsshould accompany any GLP-1 therapy to track efficacy and safety
Certain formulations are FDA-approved to lower the risk of serious cardiovascular events, such as heart attacks and strokes, in adults with heart disease who are overweight or obese
Jon Gosselin In an April 2024 Page Six interview, Jon Gosselin shared that he had managed to shed 32 pounds in two months, thanks to GLP-1 medication
How does the PlexusDx Precision Peptide Genetic Test help with combining these therapies
Results & Maintenance Many patients start noticing changes within the first few weeks, with continued progress over several months